Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Mayotte
Mayotte: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology was 0.8% in 2024. ▼ Falling
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Mayotte, 2015–2024
Source: United Nations Statistics Division, SDG Global Database.
Analysis
In 2024, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Mayotte stood at 0.8%. That is the lowest value across all 10 years on record.
The figure is down 46.7% over ten years.
Over the whole period, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Mayotte peaked at 1.5% in 2015 and was at its lowest, 0.8%, in 2022.
That places Mayotte 37th out of 215 countries with data for 2024, putting it in the top quarter.
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Mayotte, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 1.5% | — |
| 2016 | 1.3% | -13.3% |
| 2017 | 1.2% | -7.7% |
| 2018 | 1.1% | -8.3% |
| 2019 | 1.0% | -9.1% |
| 2020 | 0.9% | -10.0% |
| 2021 | 0.9% | +0.0% |
| 2022 | 0.8% | -11.1% |
| 2023 | 0.8% | +0.0% |
| 2024 | 0.8% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1.2% | 1.0% | 1.5% | 5 |
| 2020s | 0.8% | 0.8% | 0.9% | 5 |
Countries ranked near Mayotte
- 35 Kiribati 0.9% compare
- 35 Marshall Islands 0.9% compare
- 37 Mauritius 0.8% compare
- 37 Philippines 0.8% compare
- 37 Réunion 0.8% compare
- 37 Sao Tome and Principe 0.8% compare
- 37 Seychelles 0.8% compare
More development goals data for Mayotte
- Red List Index 0.8098 (2025)
- Domestic material consumption, by type of raw material 17,631 (2024)
- Domestic material consumption per capita, by type of raw material 0.054 (2024)
- Change in maximum river flow -72.9% (2024)
- Change in minimum river flow -87.9% (2024)
- River flow maximum 1.17 (2024)
- River flow minimum 0.0164 (2024)
- Average tariff applied by developed countries, most-favored nation 4.0% (2024)
- Average tariff applied by developed countries, preferential status 3.9% (2024)
- Total assistance for development, by recipient countries 605.42 (2010)
Frequently asked questions
- What is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Mayotte?
- Prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Mayotte was 0.8% in 2024, according to United Nations Statistics Division, SDG Global Database.
- What is the highest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Mayotte?
- The highest recorded value was 1.5% in 2015.
- What is the lowest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Mayotte?
- The lowest recorded value was 0.8% in 2022.
- How does Mayotte rank for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Mayotte ranks 37th out of 215 countries with data for 2024.
- Is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology rising or falling in Mayotte?
- Over the last ten years it is down 46.7%. The long-run trend across the full record is falling.
- Where does this Mayotte data come from?
- The figures come from United Nations Statistics Division, SDG Global Database, published as part of Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under UN SDG Global Database (open, attribution requested).